News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
146,966 Results
Type
Article (14407)
Company Profile (9)
Press Release (132550)
Multimedia
Podcasts (8)
Webinars (3)
Section
Business (39741)
Career Advice (309)
Deals (5379)
Drug Delivery (17)
Drug Development (18505)
Employer Resources (33)
FDA (2857)
Job Trends (3176)
News (65934)
Policy (5389)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 Biotech Bay Standard (1)
Academia (1704)
Accelerated approval (1)
Adcomms (12)
Allergies (14)
Alliances (12592)
ALS (20)
Alzheimer's disease (477)
Antibody-drug conjugate (ADC) (19)
Approvals (2853)
Artificial intelligence (67)
Autoimmune disease (1)
Automation (3)
Bankruptcy (32)
Best Places to Work (2708)
BIOSECURE Act (15)
Biosimilars (8)
Biotechnology (6)
Bladder cancer (19)
Brain cancer (9)
Breast cancer (77)
Cancer (610)
Cardiovascular disease (34)
Career advice (269)
Career pathing (4)
CAR-T (41)
Cell therapy (100)
Cervical cancer (10)
Clinical research (14280)
Collaboration (199)
Compensation (11)
Complete response letters (2)
COVID-19 (1026)
CRISPR (12)
C-suite (56)
Cystic fibrosis (22)
Data (470)
Depression (3)
Diabetes (34)
Diagnostics (1662)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (12)
Drug discovery (26)
Drug pricing (22)
Drug shortages (1)
Duchenne muscular dystrophy (14)
Earnings (9014)
Editorial (11)
Employer branding (5)
Employer resources (28)
Events (18860)
Executive appointments (142)
FDA (3098)
Featured Employer (2)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (272)
Gene editing (22)
Generative AI (2)
Gene therapy (87)
GLP-1 (108)
Government (1187)
Guidances (11)
Healthcare (4880)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (14)
Indications (3)
Infectious disease (1063)
Inflammatory bowel disease (31)
Inflation Reduction Act (3)
Influenza (7)
Intellectual property (12)
Interviews (37)
IPO (2738)
IRA (14)
Job creations (557)
Job search strategy (251)
Kidney cancer (5)
Labor market (7)
Layoffs (50)
Leadership (1)
Legal (950)
Liver cancer (21)
Lung cancer (99)
Lymphoma (38)
Machine learning (2)
Management (10)
Manufacturing (53)
MASH (10)
Medical device (2440)
Medtech (2440)
Mergers & acquisitions (2780)
Metabolic disorders (66)
Multiple sclerosis (16)
NASH (4)
Neurodegenerative disease (13)
Neuropsychiatric disorders (2)
Neuroscience (586)
NextGen: Class of 2025 (1644)
Non-profit (1886)
Northern California (432)
Now hiring (5)
Obesity (24)
Opinion (48)
Ovarian cancer (26)
Pain (21)
Pancreatic cancer (18)
Parkinson's disease (32)
Partnered (5)
Patents (31)
Patient recruitment (25)
Peanut (9)
People (15272)
Pharmaceutical (5)
Phase I (4827)
Phase II (6567)
Phase III (4327)
Pipeline (214)
Policy (69)
Postmarket research (549)
Preclinical (2208)
Press Release (18)
Prostate cancer (24)
Psychedelics (11)
Radiopharmaceuticals (47)
Rare diseases (77)
Real estate (1211)
Recruiting (14)
Regulatory (3671)
Reports (9)
Research institute (1870)
Resumes & cover letters (36)
RNA editing (1)
RSV (6)
Schizophrenia (11)
Series A (41)
Series B (18)
Sickle cell disease (20)
Southern California (398)
Spinal muscular atrophy (24)
Sponsored (1)
Startups (1071)
Stomach cancer (3)
Supply chain (14)
Tariffs (7)
The Weekly (7)
United States (4400)
Vaccines (228)
Venture capitalists (12)
Weight loss (11)
Women's health (3)
Worklife (3)
Date
Last 7 days (108)
Last 30 days (505)
Last 365 days (6738)
2025 (1874)
2024 (7242)
2023 (8722)
2022 (11561)
2021 (12942)
2020 (12297)
2019 (11092)
2018 (8180)
2017 (7397)
2016 (7464)
2015 (8756)
2014 (6506)
2013 (5351)
2012 (5460)
2011 (5675)
2010 (4824)
Location
Africa (190)
Alabama (32)
Alaska (3)
Arizona (49)
Arkansas (3)
Asia (9202)
Australia (2046)
California (1028)
Canada (337)
China (67)
Colorado (48)
Connecticut (46)
Delaware (35)
Europe (19130)
Florida (216)
Georgia (22)
Idaho (11)
Illinois (115)
India (5)
Indiana (44)
Japan (39)
Kansas (22)
Kentucky (12)
Louisiana (1)
Maine (9)
Maryland (157)
Massachusetts (753)
Michigan (27)
Minnesota (63)
Missouri (25)
Montana (7)
Nebraska (4)
Nevada (4)
New Hampshire (12)
New Jersey (472)
New Mexico (6)
New York (364)
North Carolina (156)
North Dakota (3)
Northern California (432)
Ohio (45)
Oklahoma (5)
Oregon (8)
Pennsylvania (237)
Rhode Island (7)
South America (249)
South Carolina (5)
Southern California (398)
Tennessee (21)
Texas (226)
Utah (33)
Virginia (27)
Washington D.C. (35)
Washington State (126)
West Virginia (1)
Wisconsin (10)
146,966 Results for "kennedy krieger institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Government
Calls To End Kennedy’s Leadership Follow Marks’ Abrupt Exit
Analysts at financial firm Cantor Fitzgerald are urging President Donald Trump to rethink his appointment of Robert F. Kennedy Jr. as Secretary of Health and Human Services.
April 1, 2025
·
2 min read
·
Tristan Manalac
Government
HHS Secretary Kennedy Accuses FDA Employees of Being Industry ‘Sock Puppet’
Leerink analysts warned that Kennedy’s remarks to FDA staff would likely be a negative for the biotech industry.
April 14, 2025
·
2 min read
·
Tristan Manalac
Government
Kennedy Changes Tune on MMR Vaccine as Second Child Dies of Measles
Kennedy, a long-time opponent of vaccines, stated that the MMR vaccine is “the most effective way” to combat the measles outbreak, which has already claimed the lives of two children in the U.S.
April 7, 2025
·
2 min read
·
Tristan Manalac
Government
Kennedy Senate Appearance to Address HHS Cuts Won’t Proceed This Week
Senators Bill Cassidy and Bernie Sanders asked HHS Secretary Robert F. Kennedy, Jr. to make good on a pledge to appear before the committee regularly. It is not clear if or when the hearing, which was scheduled for Thursday, will take place.
April 7, 2025
·
2 min read
·
Dan Samorodnitsky
Editorial
Kennedy’s Hunt for a Connection Between Vaccines and Autism Is a Sham
The Health and Human Services Secretary said that he will find and eliminate the cause of autism by September, an idea that suggests how little he knows about the condition.
April 17, 2025
·
3 min read
·
Dan Samorodnitsky
Vaccines
Meeting of FDA’s Vaccines Advisory Panel Canceled as Kennedy Settles Into HHS
The back-to-back high-level disruptions in vaccine policy under Robert F. Kennedy Jr. comes as the U.S. records its first death from measles since 2015.
February 27, 2025
·
2 min read
·
Tristan Manalac
New MOMENTUM Magnetic Particle Imaging Scanner installed at Kennedy Krieger Institute
The first East Coast installation of the MOMENTUM Magnetic Particle Imaging (MPI) scanner has been completed at Kennedy Krieger Institute in Baltimore, MD.
January 12, 2022
·
1 min read
Drug Development
ORYZON Starts Preclinical Collaboration on Kabuki Syndrome with Kennedy Krieger Institute and Johns Hopkins University
Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today the start of a preclinical collaboration on Kabuki Syndrome with researchers from Kennedy Krieger Institute and Johns Hopkins University.
May 3, 2022
·
5 min read
Government
RFK Jr. Again Faces Scrutiny Over Vaccines on Day 2 of Confirmation Hearing
Senators on the Health, Education, Labor and Pensions committee were critical of Kennedy’s long history as an anti-vaccine campaigner.
January 31, 2025
·
2 min read
·
Tristan Manalac
Policy
RFK Jr. Eyes Changes to Vaccines Injury Surveillance System to Deduce ‘Culprit’
Kennedy is planning modifications to the Vaccines Adverse Event Reporting System to identify whether vaccines contribute to an unstated problem. The reporting system is at the heart of the departure of CBER head Peter Marks.
April 17, 2025
·
2 min read
·
Tristan Manalac
1 of 14,697
Next